Voglhuber Julia, Ljubojevic-Holzer Senka, Abdellatif Mahmoud, Sedej Simon
Department of Cardiology, Medical University of Graz, Graz, Austria.
BioTechMed Graz, Graz, Austria.
Front Nutr. 2021 Sep 30;8:758058. doi: 10.3389/fnut.2021.758058. eCollection 2021.
The average human life expectancy continues to rise globally and so does the prevalence and absolute burden of cardiovascular disease. Dietary restriction promotes longevity and improves various cardiovascular risk factors, including hypertension, obesity, diabetes mellitus, and metabolic syndrome. However, low adherence to caloric restriction renders this stringent dietary intervention challenging to adopt as a standard practice for cardiovascular disease prevention. Hence, alternative eating patterns and strategies that recapitulate the salutary benefits of caloric restriction are under intense investigation. Here, we first provide an overview of alternative interventions, including intermittent fasting, alternate-day fasting and the Mediterranean diet, along with their cardiometabolic effects in animal models and humans. We then present emerging pharmacological alternatives, including spermidine, NAD precursors, resveratrol, and metformin, as promising caloric restriction mimetics, and briefly touch on the mechanisms underpinning their cardiometabolic and health-promoting effects. We conclude that implementation of feasible dietary approaches holds the promise to attenuate the burden of cardiovascular disease and facilitate healthy aging in humans.
全球人类平均预期寿命持续上升,心血管疾病的患病率和绝对负担也在增加。饮食限制可促进长寿,并改善包括高血压、肥胖、糖尿病和代谢综合征在内的各种心血管危险因素。然而,对热量限制的低依从性使得这种严格的饮食干预难以作为预防心血管疾病的标准做法被采用。因此,能够概括热量限制有益作用的替代饮食模式和策略正在受到深入研究。在此,我们首先概述替代干预措施,包括间歇性禁食、隔日禁食和地中海饮食,以及它们在动物模型和人类中的心脏代谢效应。然后,我们介绍新兴的药理学替代方法,包括亚精胺、NAD前体、白藜芦醇和二甲双胍,它们是有前景的热量限制模拟物,并简要阐述其心脏代谢和促进健康作用的潜在机制。我们得出结论,实施可行的饮食方法有望减轻人类心血管疾病负担并促进健康衰老。